Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 32

Results For "Ltd."

576 News Found

Evonik and Shandong Vland Biotech form JV in China with focus on gut health products for animals
News | October 14, 2023

Evonik and Shandong Vland Biotech form JV in China with focus on gut health products for animals

Evonik China and Shandong Vland Biotech agreed to build a joint venture to expand their presence in gut health solutions products for farm animals globally


Mitsui invests in Lokavant Holdings
News | October 09, 2023

Mitsui invests in Lokavant Holdings

Lokavant provides clinical trial intelligence


Lupin receives tentative approval from USFDA for Tolvaptan Tablets
Drug Approval | October 07, 2023

Lupin receives tentative approval from USFDA for Tolvaptan Tablets

Tolvaptan Tablets (RLD Jynarque) had estimated annual sales of USD 287 million in the U.S. (IQVIA MAT August 2023)


Zydus announces IND clearance of a novel Anti-PCSK9 candidate
Diagnostic Center | October 03, 2023

Zydus announces IND clearance of a novel Anti-PCSK9 candidate

Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity


Advent International announces the completion of the acquision of Suven Pharma
News | September 30, 2023

Advent International announces the completion of the acquision of Suven Pharma

New Board of Directors and management team at Suven Pharma also appointed


Cosmo and Glenmark sign distribution and license agreements for Winlevi in Europe and South Africa
Supply Chain | September 28, 2023

Cosmo and Glenmark sign distribution and license agreements for Winlevi in Europe and South Africa

Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries


Lupin acquires five brands from Menarini
News | September 23, 2023

Lupin acquires five brands from Menarini

Lupin has been exclusively marketing these brands in the Indian market since July 2021


Biocon Biologics receives European Commission approval for biosimilar of Aflibercept ‘Yesafili’
Drug Approval | September 21, 2023

Biocon Biologics receives European Commission approval for biosimilar of Aflibercept ‘Yesafili’

The centralized marketing authorization granted by the EC is valid in all EU Member States as well as in the European Economic Area (EEA) countries Iceland, Liechtenstein and Norway


IIT Kanpur signs MoU with Sensa Core for technology transfer of novel strip to analyse bilirubin in human blood
News | September 13, 2023

IIT Kanpur signs MoU with Sensa Core for technology transfer of novel strip to analyse bilirubin in human blood

The non-enzymatic electrochemical sensing strip can simultaneously detect the direct and total bilirubin in a single drop of blood, and provide the concentrations within a minute